Long Island Drug-Impaired Driving
Accident Lawyer

Legal Analysis

New York’s Drug-Impaired Driving Law

New York’s Vehicle and Traffic Law addresses drug-impaired driving through two primary statutes. VTL §1192(4) — Driving While Ability Impaired by Drugs (DWAI-Drugs) — makes it unlawful to operate a motor vehicle while the driver’s ability is impaired by the use of any drug defined under Public Health Law §3306. This encompasses cannabis, opioids (including lawfully prescribed narcotics), benzodiazepines, hallucinogens, stimulants, and other controlled substances. Unlike the per se alcohol standard under VTL §1192(2), there is no specific blood concentration threshold for drug impairment: any degree of impairment caused by the drug is sufficient to establish a violation.

VTL §1192(4-a) — Driving While Ability Impaired by the Combined Influence of Drugs or of Alcohol and any Drug — addresses the especially dangerous scenario of combined impairment. When a driver has consumed both alcohol and drugs, or multiple drugs simultaneously, the impairing effects are frequently synergistic: benzodiazepines and alcohol, for example, each amplify the other’s sedating and coordination-impairing effects far beyond what either would cause alone. DWAI-Combination charges are common in cases involving opioid painkillers combined with alcohol, or benzodiazepines combined with cannabis.

VTL §114-d defines the Drug Recognition Expert (DRE) and establishes the legal basis for DRE evaluations in New York. A DRE is a specially trained law enforcement officer who conducts a structured 12-step protocol to assess whether a driver is impaired by drugs, and if so, what category of drug is likely responsible. The DRE evaluation includes pupil measurements under different lighting conditions, vital sign recording, psychomotor performance testing, examination for physical indicators of drug use, and an overall opinion. DRE reports are admissible in both criminal and civil proceedings and provide a detailed contemporaneous record of the driver’s impairment that is difficult to contest.

In civil litigation, a violation of VTL §1192(4) or §1192(4-a) — established through toxicology evidence, a DRE evaluation, or a criminal conviction — provides substantial evidence of negligence. While New York does not apply a strict negligence per se doctrine to drug impairment in the same way as some traffic violations, the statutory violation is admissible as evidence of negligence and carries powerful persuasive weight with juries. A driver who operated a vehicle while impaired by drugs, knowing that impairment was a possibility, is not merely negligent — they made a deliberate choice that New York law has specifically criminalized.

Cannabis and Marijuana Impairment on Long Island Roads

Following New York’s legalization of adult-use cannabis under the Marijuana Regulation and Taxation Act (MRTA), cannabis impairment behind the wheel has become an increasingly common factor in Long Island car accident cases. The legality of cannabis does not change the law governing impaired driving: operating a vehicle while impaired by cannabis is a criminal violation under VTL §1192(4) and a basis for civil liability, regardless of whether the driver had a lawful right to possess and use cannabis.

Cannabis impairment presents unique evidentiary challenges. Unlike alcohol, there is no breath test for THC — blood and urine testing are the primary chemical testing methods. THC (delta-9-tetrahydrocannabinol) is detectable in blood for a shorter window than in urine, but blood THC concentration does not correlate as directly with impairment as blood alcohol concentration does with alcohol impairment. A driver may have a measurable THC blood level days after last use with no functional impairment, or may be significantly impaired with a relatively low measured concentration immediately after use.

This is precisely why the DRE evaluation under VTL §114-d is so important in cannabis impairment cases. DRE officers are specifically trained to identify cannabis impairment through physical indicators: elevated pulse, reddened conjunctiva (bloodshot eyes), odor of cannabis, slowed reaction time, impaired divided attention, and the characteristic pupil response associated with cannabis use. A well-documented DRE evaluation corroborated by a positive blood or urine test creates a powerful civil evidence record even without a per se concentration threshold.

Cannabis impairment is also increasingly relevant in commercial vehicle cases on Long Island. Delivery drivers, rideshare operators, and other commercial drivers who operate vehicles while cannabis-impaired expose their employers to liability for negligent hiring, negligent retention, and negligent entrustment alongside direct vicarious liability. These commercial cases often involve substantially higher policy limits than individual driver coverage, dramatically increasing the maximum available recovery. For related automobile accident claims, see our Long Island car accident lawyer page.

Prescription Drug Impairment: A Growing Cause of Long Island Crashes

Prescription drug impairment is among the most underreported causes of serious car accidents on Long Island. Drivers who have been prescribed opioid painkillers, benzodiazepines (such as Xanax, Klonopin, or Valium), sedating antidepressants, sleep medications (such as Ambien), muscle relaxants, or anti-anxiety medications frequently underestimate or disregard their impairment. Many of these medications carry explicit FDA labeling and package insert warnings against operating motor vehicles — warnings the driver received and ignored.

The civil liability framework for prescription drug impairment is straightforward: a driver who operates a motor vehicle after taking medication that impairs their ability to drive safely, knowing or having reason to know of the impairing effect, is negligent. The prescription status of the drug is legally irrelevant to liability. The relevant questions are: (1) was the driver impaired?; and (2) did they know or should they have known that the medication would impair their driving? The answer to both is typically yes when medication packaging, prescribing physician notes, and pharmacy counseling records document impairment warnings. Additionally, under CPLR §4547, evidence of subsequent remedial measures — such as a prescribing physician later advising against driving — may be addressed in ways that support the underlying negligence theory.

Prescription drug cases also frequently involve the prescribing physician or pharmacy as additional parties. When a physician prescribed a medication in doses or combinations known to be highly impairing without adequately counseling the patient against driving, or when a pharmacist failed to provide required drug interaction warnings, those healthcare providers may have independent liability. These additional parties mean additional insurance coverage — and a greater total recovery for our clients. For comparison with alcohol-impaired driving claims, see our drunk driving accident lawyer page.

What Damages Can You Recover After a Drug-Impaired Driving Crash?

Victims of drug-impaired driving accidents on Long Island may recover the same categories of damages available in any serious car accident case: economic damages for documented financial losses, and non-economic damages for pain, suffering, and loss of enjoyment of life. In cases involving especially egregious conduct — such as a driver who knowingly drove while impaired by illegal drugs or while ignoring clear prescription warnings — the moral weight of the defendant’s conduct significantly increases the settlement and trial value of the case.

Economic damages include: all past and future medical expenses (emergency treatment, surgery, hospitalization, rehabilitation, physical therapy, medication, and long-term care costs); past and future lost wages and diminished earning capacity; property damage; and out-of-pocket expenses related to the injury and recovery.

Non-economic damages cover pain and suffering, physical disability, loss of enjoyment of life, emotional distress, disfigurement, and loss of consortium. New York does not cap non-economic damages in personal injury cases, but recovery requires satisfying the serious injury threshold under Insurance Law §5102(d): fracture, significant disfigurement, permanent loss of use, permanent consequential limitation, significant limitation of a body function or system, or the 90/180-day category.

Under CPLR §1411, New York’s pure comparative negligence rule reduces your recovery proportionally by your percentage of fault but does not bar recovery even if you were partially at fault. The insurer will attempt to inflate your assigned fault percentage — our firm builds the evidence record to resist those arguments and maximize recovery. Under Insurance Law §3420(d), insurers have specific obligations regarding timely denial of coverage and notice of disclaimer — requirements we monitor closely to prevent improper coverage denials from reducing available insurance proceeds.

Drug-impaired driving crashes often produce full-speed impacts because the impaired driver’s reaction time and judgment are severely compromised. High-speed collisions generate serious injury patterns: traumatic brain injury, cervical and lumbar disc herniations requiring surgery, spinal fractures, torn ligaments, and in the most severe cases, spinal cord injuries and wrongful death. These injuries frequently satisfy multiple threshold categories and support maximum non-economic damages at trial. For a complete overview of car accident damages on Long Island, see our Long Island car accident lawyer page.